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Intellectual disability (ID) disorders are genetically and phenotypically extremely heterogeneous. Can this complexity be depicted in a
comprehensive way as ameans of facilitating the understanding of ID disorders and their underlying biology?We provide a curated data-
base of 746 currently known genes, mutations in which cause ID (ID-associated genes [ID-AGs]), classified according to IDmanifestation
and associated clinical features. Using this integrated resource, we show that ID-AGs are substantially enriched with co-expression,
protein-protein interactions, and specific biological functions. Systematic identification of highly enriched functional themes and
phenotypes revealed typical phenotype combinations characterizing process-defined groups of ID disorders, such as chromatin-related
disorders and deficiencies in DNA repair. Strikingly, phenotype classification efficiently breaks down ID-AGs into subsets with signifi-
cantly elevated biological coherence and predictive power. Custom-made functional Drosophila datasets revealed further characteristic
phenotypes among ID-AGs and specific clinical classes. Our study and resource provide systematic insights into the molecular and clin-
ical landscape of ID disorders, represent a significant step toward overcoming current limitations in ID research, and prove the utility of
systematic human and cross-species phenomics analyses in highly heterogeneous genetic disorders.Introduction
Intellectual disability (ID) affects as much as 2% of our
population and is characterized by significant limitations
in intellectual functioning and adaptive behavior.1,2
Because of its high frequency, limited treatability, and
required lifelong care, ID is an important socioeconomic
and health-care issue.
The clinical presentation of ID is highly heterogeneous.
It can range from learning difficulties to profound cogni-
tive impairment, and it can occur either non-specifically
without further anomalies or in a more complex, syn-
dromic context. A large proportion of ID is caused by mu-
tations in single genes (ID-associated genes [ID-AGs]).
Identification of these genes is still largely incomplete,3,4
limiting our understanding of the underlying biology.
This makes ID a major challenge in diagnostics and trans-
lational medicine.
Whereas studies on specific subgroups of ID dis-
orders have indicated that convergent molecular path-
ways underlie common phenotypic aspects,5–7 ID-AGs
on a more global scale (yet not systematic) have been
argued to differ from genes implicated in autism in that
they show poor biological convergence.8 A comprehen-
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Here, we provide a systematic, curated ID-AG catalog
with associated core phenotypes and introduce a clinical
classification system, accessible to other scientists in an
interactive web-based database. Integration of custom-
made and public data into this resource allowed resolving
ID-AGs and ID disorders into biologically meaningful sub-
groups with significantly increased co-expression, protein
interactions, and specific functions. Our analyses also
identified typical phenotype combinations characterizing
ID disorders that are linked to specific molecular processes,
such as chromatin regulation and DNA repair, and found
that public datasets contain patterns that provide insights
into ID pathology and increase predictive power. Finally,
we provide two large-scale functional ID-AG datasets
generated inDrosophila and use these to define further pre-
dictive patterns that underlie ID.Material and Methods
ID-Associated Gene Catalog
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Figure 1. Systematic Analyses of Genes Implicated in ID Reveal Functional Groups and Molecular Modules
(A) Gene Ontology-based annotation of ID-AG function. Bar diagrams show enrichments of ID-AGs in each of the indicated Gene
Ontology-based groups against the genome-wide background. The total number of genes per group is displayed in the respective bar.
(Benjamini-Hochberg, *padj < 0.05, **padj < 0.01, ***padj < 0.001.)
(legend continued on next page)
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(1) Low evidence, e.g., genetic data based on only one or
two single individuals with de novo mutations or a single
family with a missense mutation (from 2014 on); gene-dis-
rupting translocations or deletions but no mutational
confirmation of the candidate gene in other individuals;
or clinical description of the disorder without genetic
testing or confirmation.
(2) Pure neurodegenerative manifestation, indicated by sec-
ondary onset of intellectual disability with regression of
initial normal abilities or by a progressive disease course
with deterioration of cognitive abilities.
(3) Very early lethality, thus precluding proper assessment of
psychomotor development.
(4) Treatability, indicated by avoidance of decline in cognitive
ability by substitution of certain factors, e.g., consequences
of hypothyroidism, which can be avoided by thyroid hor-
mone substitution.
(5) Neurologic phenotype without a clear indication of cogni-
tive impairment.
The excluded genes were compiled in an ID-AG candidate list
and are available in the Systems Biology Approaches to ID (SysID)
database (see Web Resources). Two versions of the ID-AG list were
used in this study: (1) a set of 388 ID-AGs, published as of mid-
2010, for the basis of the in-house Drosophila screens and (2) a
larger set of 650 ID-AGs, published as of January 2014, for all
non-Drosophila analyses.
Clinical Classification
The large clinical heterogeneity of ID disorders comprises isolated
(non-syndromic) ID, syndromic ID accompanied by various
specific clinical phenotypes, and multisystemic disorders where
ID constitutes only one of many aspects. Moreover, ID varies in
severity and penetrance. In order to obtain a systematic and ver-
satile yet manageable amount of phenotypic information, we
designed a bipartite phenotype-based classification system for
ID disorders. The classification consists of six higher-order su-
per-classes comprising nine clinical classes according to the
occurrence of non-syndromic or syndromic ID with or without
congenital malformations (‘‘syndromicity,’’ x axis in Figure 2A)
and according to manifestation (e.g., atypical), severity, and
penetrance of ID, the latter two of which correlate with each
other (‘‘manifestation, severity, and penetrance,’’ y axis in
Figure 2A; see also Figure S2). In the case of genetically heteroge-
neous disorders, only gene-specific clinical information was used
for the respective phenotype classification. A clinical expert an-
notated the phenotypic classification, and a second clinical
expert revised the main classes independently. Discrepancies
were discussed and jointly agreed on. In addition, ID-accompa-
nying phenotypes for all ID disorders in the list were assembled.
These comprise 27 additional features describing further symp-
toms and anomalies of various organ systems (Figure 2B and
Figure S2). Letters A–X indicate the presence of specific clinical
features and were added when the (estimated) reported frequency
of the respective symptom was at least 20%–30%. A confidence
criterion ‘‘limited number of affected individuals’’ was imple-(B) Physical PPI network of ID-AG products. Circles indicate highly c
proximity (Figure S1). Genes directly connecting to communities ar
nected communities. Dark gray indicates nodes without associated
at least a first-degree connection to communities. ID-AGs without co
The Amermented in the database and indicates limited availability of clin-
ical information.
SysID Database
ID-AG-related information includes a short gene description
and the human gene info (Entrez ID, Ensembl ID, HUGO gene
name, Human Protein Reference Database [HPRD] ID, synonyms,
Gene Ontology-based terms, and chromosomal location). Gene-
related disease information is provided per associated disease
and includes OMIM disease numbers and mode of inheritance.
Further clinical information is provided either by a non-vocabu-
lary-controlled summary of characteristic symptoms or by either
a PMID fromGeneTest review entries or a primary reference (Table
S1). Furthermore, Drosophila orthologs and identified phenotypes
were uploaded into the database (CG number; FlyBase ID, gene
name, and symbol; Vienna Drosophila Resource Center [VDRC]
RNAi line identifiers; and phenotypes), as shown in Table S2.
Candidate genes associated with autismwere annotated according
to the Simons Foundation’s SFARI database.10 Only genes of high-
confidence categories S and 1–3 were considered. The URL for the
SysID database is provided in the Web Resources.
Gene Ontology-Based Analysis
We used Golem v.2_111 to manually assemble 32 Gene Ontology-
based groups from related Gene Ontology12 terms, and we down-
loaded associated genes and matched them to Entrez IDs. We used
terms of biological process (BP), molecular function (MF), and
cellular component (CC) according to the authors’ knowledge
and research about processes relevant to ID (Table S3).
Protein-Protein-Interaction Network
For analysis of protein-protein interactions (PPIs), we created a
human-specific PPI network containing physical interactions be-
tween proteins. Using Entrez IDs, we merged BioGrid 3.2.108
(release January 1, 2014)13 interactions based on physical associ-
ations (association, direct interaction, physical interaction, and
co-localization with additional biochemical evidence, together
ca. 97% of all BioGrid interactions) with PPIs from HPRD14
(release 9, April 13, 2010). After removal of duplicates and self-
loops, this reference network contained 15,511 proteins and
138,029 connections, including 610 ID-AGs with 505 connec-
tions (Figure 1). We used this reference PPI network for all
manually performed analyses of enrichment, PIE (physical inter-
action enrichment) scores, and connectivity.
Community Clustering
We hierarchically clustered PPI communities obtained from the
R package linkcomm15 on the basis of the number of shared nodes
(after using the Jaccard coefficient to score the pairwise similar-
ities; tree cutoff ¼ 0.99) and visualized them as circles in
Figure 1B and Figure S2.
Clustering ID-Accompanying Phenotypes
We determined the binary matrix of ID-accompanying
phenotypes per gene on the basis of the computed row andonnected ID-AG communities; similar colors illustrate functional
e colored if they share Gene Ontology-based terms with the con-
Gene Ontology-based terms, and light gray indicates nodes with
nnections to other ID-AGs are not shown.
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column dendrograms and used gplots to visualize them as a
heatmap.16
Network Visualization and Figures
Network visualization was carried out with Cytoscape (v.3.1.1)17
and Adobe Illustrator CS5.
Multiple-Testing Corrections
When performing multiple comparisons, we applied Benjamini-
Hochberg corrections to control for the false-discovery rate. We
determined Benjamini-Hochberg-adjusted p values (padj) with
the R-stats package (v.2.16.0) and the number (n) of p values
obtained within the test (i.e., n ¼ 10 in a test of nine main clinical
classes [1–8b] plus the group ‘‘all 650 ID-AGs,’’ or n¼ 28 in a test of
27 accompanying phenotypes [A–X] plus the group ‘‘all 650
ID-AGs genes’’).
PIE Score
We calculated PIE scores and associated p values for all ID-AGs
against direct PPIs from our reference network by using the PIE
algorithm18 to account for biases in the number of reported inter-
actions for disease-associated genes. Random protein groups were
formed by number-matched sub-samplings selected from the 650
ID-AG set.
Enrichment Analyses
Enrichment for human and Drosophila datasets was calculated as
follows: (a/b)/[(c  a)/(d  b)], where a is the number of genes
that are in a class or ID-accompanying phenotype and have a spe-
cific feature, b is the number of genes in that class or ID-accompa-
nying phenotype, c is the number of genes with that specific
feature, and d is the total number of genes. For analyses of human
datasets (phenotypes, Gene Ontology-based terms, and human
postsynaptic density [hPSD]), we used the human genome with
an estimated 20,500 genes or the 650 ID-AG set as a background,
as indicated. For analyses of the generated phenotype groups for
the Drosophila orthologs of the 388 ID-AG set, we used the back-
ground of all targeted fly orthologs. Uncorrected p values were
determined with a two-sided Fisher’s exact test in R.
Co-expression Networks Based on BrainSpan and
GTEx
WeusedtheBrainSpan19developmental transcriptomedataset (RNA
sequencing with Gencode v.10) to examine the overrepresentation
of highly co-expressed genes over all or within brain regions and
time points, and we used GTEx20 data to determine overrepresenta-
tion of highly co-expressed genes over various tissues. To examine
the overrepresentation of highly co-expressed genes among all ID-
AGs, ID classes, and ID-accompanyingphenotype groups in relation
to the rest of the genome, we concatenated the expression coeffi-
cients per gene over all time points (embryonic stage to adulthood)
and brain regions in the BrainSpan dataset. Additionally, we calcu-
lated co-expression enrichment for ID-AGs per brain region over
all time points as well as enrichment for all ID-AGs per brain region
at pre- andpostnatal stages. Also, for theGTExdataset, we combined
expression values for all tissues.We calculated the co-expression cor-
relation for gene pairs among 650 ID-AGs, per phenotype group
(main classes 1–8b and ID-accompanying phenotypes A–X), and
for random groups. For each phenotype group and the 650 ID-
AGs, 10,000 random groups out of the entire gene-expression data-
sets met the following criteria: (1) same group size (e.g., main class152 The American Journal of Human Genetics 98, 149–164, January 71 contains 65 genes, so 10,000 random groups contain 65 genes),
(2) similar distribution of coding-sequence (CDS) length (as
described in Honti et al.21), and (3) similar number of co-expressed
genes (i.e., with a correlation coefficient > 0.3) in the complete
network.Wethencalculatedandcomparedthe sumofco-expression
coefficients for the real and random groups, and we again only
included gene pairs with a correlation coefficient > 0.3. We calcu-
lated p values by comparing howmany of the 10,000 co-expression
coefficients of randomgroupswere equal or higher than those of the
corresponding test group, and we corrected for multiple testing. We
calculated the enrichment score by dividing the sum of the co-
expression coefficient per test group by the mean of the 10,000
random groups per group of interest.
For the co-expression of ID classes or phenotype groups, we
compared the sum of co-expression values within ID classes or
phenotype groups with the sum of co-expression values when
the 650 ID-AGs were randomly distributed over the ID classes or
phenotype groups, while considering group size.
Enrichment of Connectivity within ID Phenotype
Classes
We calculated the overall connectivity of main clinical classes and
ID-accompanying phenotypes among 650 ID-AGs by the median
of (1) the number of PPIs based on our reference PPI network per
clinical classe or ID-accompanying phenotype, (2) the co-expres-
sion levels per clinical class according to BrainSpan, and (3) the
co-expression levels per ID-accompanying phenotype according
to GTEx. For randomized classes, all 650 genes were shuffled be-
tween all classes controlled for class size, and the median of con-
nectivity of all classes was calculated. This randomization was
repeated 10,000 times. The enrichment (number of interactions
divided by the median of the connectivity of random samples)
was calculated, and p values (number of random samples with a
connectivity equal to or higher than the real gene set) were ob-
tained. This was done for bothmain clinical classes and ID-accom-
panying phenotypes.
Precision-Recall Analysis
To test whether the functional coherence of genes associated with
the same ID class, ID super-class, or ID-accompanying phenotype
manifests in their increased predictability, we performed leave-
one-out cross-validations by taking advantage of an integrated
phenotypic-linkage network described elsewhere.21 To assess the
predictability of a class, we rank ordered all 17,011 genes in the in-
tegrated network by the sum of their link weights to the ten class
genes most strongly linked to them, and the highest-ranking
genes were predicted to be associated with the given class. The
results of these analyses were represented by precision-recall
curves, which show the proportion of true positives at different
levels of coverage of known class genes (recall) in the predictions.
To indicate the significance of the results, we evaluated expected
precision values with randomly selected gene sets sub-sampled
from among the 650 ID-AGs; the area they covered was color
coded according to the corresponding p value. For evaluating all
650 ID-AGs, we used random genes controlled for both node de-
gree and CDS length from the integrated network to calculate
the expected precision values.
Controlling for Node Degree and CDS Length
The node degree of a given gene was defined as the number of
genes linked to this gene in the network. To control for both, 2016
node degree and CDS length during the co-expression randomiza-
tions based on BrainSpan and GTEx and precision-recall calcula-
tion, we selected random genes that matched the node degree
and CDS length of the studied genes. For each of the studied genes,
we assigned a list of 100 genes with the same or most similar node
degree and CDS length by using the longest CDS of each gene. We
normalized the node degrees and CDS lengths and calculated the
Euclidean distance between genes on the basis of these two mea-
sures. We used this Euclidean distance to form lists of the 100
genes most similar to each of the studied genes. We then assem-
bled random gene sets by selecting one random gene from each
of these lists.21
Fly Stocks and Breeding Conditions
For the neuronal screen, we used an elav-Gal4 promoter line from
the Bloomington stock center (BL25750: P{w[þmW.hs] ¼ GawB}
elav[C155] w[1118]; P{w[þmC] ¼ UAS-Dcr-2.D}2), and for the
wing screen, we used the trp05/MS1096 promoter line from
the Bloomington stock center (BL25706: w[1118] P{w[þmW.hs] ¼
GawB}Bx[MS1096]; P{w[þmC] ¼ UAS-Dcr-2.D}2). Stocks and
crosseswere cultured according to standard procedures andon stan-
dard fly food. Crosses for the neuronal screen were raised on 28C
and 60% humidity, and crosses for the wing-screen were raised on
25C and 60% humidity, both at a 12/12 hr day/night cycle.
Drosophila Orthology and Genetic Manipulation
We mapped 388 human ID-AGs identified as of mid-2010 to
their corresponding orthologs in Drosophila melanogaster by using
Ensembl’s orthology classes (Ensemblv72_June2013),22 treefam
annotations,23 and manual curation. One-to-one and one-to-
many (fly-to-human) criteria identified 294 orthologs for 388
human ID-AGs. For conditional knockdown, we used the UAS-
GAL4 system24 in combination with UAS-RNAi lines from the
VDRC. Progenies from a cross of the Gal4 driver to the genetic
backgrounds of the UAS-RNAi libraries (vdrc60000, vdrc60100)25
served as controls in all experiments and showed wild-type
morphology and behavior.
Quality-Control Criteria of RNAi Lines
We used at least two independent constructs for each ID-AG (one
from the GD [p-element-based transgenes] and one from the KK
[phiC31-based transgenes] library) when available and selected
RNAi lines with high s19 values, (0.98–1.00 in 97% of all cases;
see the SysID database in the Web Resources), thereby exceeding
the recommended threshold of 0.85 for ensuring high reproduc-
ibility.26 None of the described phenotypes was observed in the
non-induced UAS-RNAi stocks.
Negative-Control Gene Set
We generated random lists of 35 conserved genes until we identi-
fied one that (1) contained no ID-AGs and (2) included genes that
showed average expression in each of the three nervous system tis-
sues (larval CNS, adult brain, and thoracic ganglion) in FlyAtlas.27
Like for ID-AGs, at least two independent RNAi-constructs against
these genes were used if available.
Neuronal Screen with the Island Assay
The assay was performed as previously described28 with minor
modifications. In brief, if gene silencing did not result in lethality,
progenies of the appropriate genotype were collected in batches of
20 and either tested 2 days after collection (4–6 days old) or keptThe Ameron standard food (changed to fresh food every other day) for later
testing (14–16 days old). Phenotypes observed at the first testing
point were annotated as ‘‘early,’’ and those at the second were an-
notated as ‘‘late.’’ A minimum of 10–20 flies were tested during the
same time window of the day (10 a.m. to 3 p.m.). For the island
assay, we used a soapy water bath with an elevated platform
(‘‘island,’’ 5 3 10 cm) in the middle. We evaluated locomotion
defects by assessing the flies’ ability to immediately fly away after
being dropped from their vial onto the platform from about 10 cm
height. Fractions of the population flying away immediately
(no phenotype) or remaining on the platform (phenotype) were
scored. Behavior of the remaining flies was further evaluated
(‘‘walker’’ [flies walking on the platform], ‘‘sitter’’ [flies not moving
on the platform], ‘‘jumper’’ [flies jumping on the platform], or
a combination thereof). Whenever the independent RNAi
lines tested for a particular gene did not all show the same pheno-
type, abnormal fly behavior or lethality was confirmed by two in-
dependent experiments blind to genotype. The phenotypes ‘‘pro-
gression’’ and ‘‘recovery’’ were assessed according to increasing
phenotype frequency and/or tendency over age. RNAi-to-gene
translation was done in a collective manner (all phenotypes
observed among the tested RNAi lines were associatedwith the tar-
geted Drosophila gene and its human ortholog) for the following
phenotypes: developmental lethality, adult lethality, and all
behavioral phenotypes (early or late walker, early or late sitter,
and early or late jumper). Exceptions were the categories ‘‘pheno-
type progression,’’ ‘‘phenotype recovery,’’ and ‘‘no tendency,’’ for
which only the strongest obtained phenotype was considered
(whereby developmental lethality was stronger than behavioral
phenotype). ‘‘Any phenotype’’ was annotated upon observation
of at least one phenotype, and ‘‘no phenotype’’ was annotated if
no phenotype was found in any of the tested RNAi lines per
gene. See Table S2 for an overview of all observed phenotypes
per gene within the neuronal screen (264 ID-AGs and 31 non-
ID-AGs tested).
Wing Screen
For each genotype, we assessed the viability and the overall
appearance of the wing before mounting the wings for closer
phenotype evaluation. Of each genotype, three to five right wings
of 8-day-old males were collected and dehydrated in a succession
of three solutions (30/70 glycerol/isopropanol, 60/40 glycerol/iso-
propanol, and 90/10 glycerol/isopropanol, each for 10 min).
Wings were mounted in 100% glycerol and stored at 4C. The
following phenotype categories were evaluated for the screen
(Axio Imager Z1, magnification 53, 103, or 203): wing shape
(curled and cupped, size, and adhesion), posterior margin
(notched or with missing hairs), wing fields (trichome polarity
[missing, density, or disorganized], morphology, and other aspects
[i.e., pigmented spots]), veins (missing and/or extra), and bristles
(sensory organs). RNAi-to-gene translation for the wing screen
was collective (see Neuronal Screen with the Island Assay above).
See Table S2 for an overview and more detailed description of all
observed phenotypes per human gene of the 261 ID-AGs and 31
non-ID-AGs tested.Results
Mutations in More Than 650 Genes Cause ID
We assembled a systematic, manually curated catalog of
650 ID-AGs (as of January 2014; Table S1) according toican Journal of Human Genetics 98, 149–164, January 7, 2016 153
criteria specified in the Material and Methods. Of the 650
ID-AGs, 101 (16%) are implicated in more than one spe-
cific ID disorder. Mutations in 400 of the genes (62%)
follow autosomal-recessive inheritance, mutations in 139
genes (21%) are autosomal dominant (mostly de novo),
and 103 ID-AGs (16%) are X-linked. Our SysID database
(see Material and Methods) currently covers 777 ID-AGs
(updated December 2015) with related phenotypic and
functional data plus 389 ID-associated candidate genes.
Biological Functions of ID-Associated Genes
To characterize the functional coherence and connectivity
among the complete set of 650 ID-AGs, we collected data
from genome-wide resources of annotated gene function,
physical PPIs, and gene co-expression. We used Gene
Ontology-based annotations to ask, given the genome-
wide frequency of genes in each of these processes, which
of them are most enriched and thus most prone to bear
ID-AGs. We found 560 ID-AGs (86%) to associate with at
least one of the 32 Gene Ontology-based annotations
shown in Figure 1A. Whereas the largest groups of ID-AGs
were associated with metabolism, transporters, nervous
system development, RNA metabolism, and transcription,
the most enriched terms were hedgehog signaling, gluta-
mate signaling, peroxisomes, glycosylation, and cilia
(Figure 1A). Frequently discussed themes in ID, such as
synaptic and chromatin-related processes,29–32 although
statistically significant enriched, were found to belong to
neither the biggest nor the most enriched groups.
ID-Associated Genes Show High Connectivity and
Significant Co-expression
We next asked whether ID-AGs and their products,
ID-associated proteins, also show increased molecular
connectivity, modularity, and co-expression. Constructing
PPI networks from HPRD14 and BioGRID13 physical-inter-
action data, we found that nearly half (308 [47%]) of
all ID-associated proteins physically interact with other
ID-associated proteins. Of these, 66 are connected in small
modules (pairs and tri- and quadromers), whereas 242 ID-
associated proteins together form a single major network
with 462 interactions (Figure 1B). Using the PIE approach
to correct for inquisitional biases18 revealed that the 650
ID-AGs show more than a 30% increase in connectivity
(PIE ¼ 1.32, p < 0.0001) over randomly chosen proteins
with the same number of known interactions.
To identify molecular units within the identified ID
networks, we applied unsupervised community clustering
on the protein interactions.15 This identified a molecular
landscape of 21 highly intraconnected and partly intercon-
nected ID modules (Figure 1B and Figure S1).
Furthermore, we found that ID-AGs, on average, show
significantly enriched co-expression in two recently gener-
ated high-content gene-expression datasets, one specif-
ically relevant to the brain (BrainSpan;19 E ¼ 1.04, p ¼
0.0001) and one representing multiple organ systems
(GTEx;20 E ¼ 1.1, p < 0.0001). Interestingly, within the154 The American Journal of Human Genetics 98, 149–164, January 7brain, the hippocampus, a primary region controlling
learning and memory, shows the highest level of co-
expression of ID-AGs (E ¼ 1.21, padj < 0.0001; Table S4).
In summary, despite their extreme genetic heteroge-
neity, known ID-AGs show significantly elevated co-
expression in the brain, particularly in a region relevant
to cognitive processes. Moreover, the encoded proteins
converge on a limited number of molecular networks
and show considerable functional coherence.
An Expert-Curated, Phenotype-Based ID-
Classification System
In order to obtain a systematic and versatile yet manage-
able amount of phenotypic information on clinically
extremely heterogeneous ID disorders, we designed a
bipartite phenotype-based classification system and anno-
tated all ID disorders and genes accordingly. First, we
defined ten main clinical classes relating to (1) manifesta-
tion, severity, and penetrance and (2) syndromicity of ID,
and these are summarized in six super-classes (Figure 2A).
The number of ID-AGs in the ten clinical classes varies
from 19 (class 3) to 183 (class 5), with the exception of
class 9, which harbors only one gene (Figures S2A and
S2C). Second, 27 ID-accompanying phenotype categories,
including structural malformations of various organ sys-
tems and functional or behavioral anomalies, were estab-
lished (Figures 2B and S2B).
ID-Accompanying Phenotypes Are Characteristic of
the Underlying Molecular Processes
We first performed hierarchical clustering of ID-AGs
and their associated ID-accompanying phenotypes to
map phenotypically similar groups of ID-AGs and to sys-
tematically unravel which ID-accompanying clinical fea-
tures co-occur most frequently (Figure 3). Furthermore,
Gene Ontology-based analysis revealed that one to several
molecular processes were significantly overrepresented in
ID-AGs associated with specific ID-accompanying pheno-
types than among all ID-AGs. For example, short stature
and ectodermal anomalies were much more co-morbid
and enriched in genes operating in MAPK, growth factor
signaling, and DNA repair than in all ID-AGs (Figure 3,
right-hand side) and especially the whole genome (data
not shown). Endocrine abnormalities and obesity were
tightly linked with each other and co-occurred in a cluster
of 18 ID-AGs and ID disorders dominated by genes with a
function in cilia (Figure 3, red box). Epilepsy, neurological
and metabolic abnormalities, myopathy, lethality, and
non-structural MRI abnormalities co-occurred in a cluster
of 20 genes enriched with mitochondrial function (blue
box). Microcephaly and behavioral abnormalities were
linked to two adjacent ID clusters comprising 20 genes en-
riched with chromatin-related function (yellow boxes).
Twenty ID-AGs presenting merely with behavioral abnor-
malities were enriched with synaptic function (turquoise
box). Of note, each of these clusters also contains genes
that have not been previously associated with these, 2016
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Figure 2. Bipartite Clinical ID-Classifica-
tion System
(A) Main clinical classes. The ‘‘syndro-
micity’’ axis of ID entities is defined as
follows: classes 1, 4, and 7 comprise
disorders that are syndromic with struc-
tural malformations (SWSM); classes 2,
5, and 8 include disorders that are syn-
dromic without structural malforma-
tions (SWOSM); and classes 3, 6, and 9
comprise non-syndromic (NS) ID disor-
ders. The ‘‘manifestation, severity, and
penetrance’’ axis of ID entities is defined
as follows: classes 1–3 contain disorders
with severe and fully penetrant manifes-
tation of ID (CS), classes 4–6 include dis-
orders with mild to moderate or very var-
iable ID (CM), and classes 7–9 comprise
disorders with ID in a rare (8a) or atypical
(e.g., progressive, neurodegenerative fea-
tures) (8b) manifestation (NC).
(B) ID-accompanying phenotypes: ID-accompanying clinical features that occur with an estimated frequency of >20% within the
respective disorder. Abbreviations are as follows: lifesp, lifespan; and an, anomalies. Clinical features marked with an asterisk
are explained as follows: progression/regression, progression of disease and regression of development; neurological symptoms,
e.g., hypotonia, ataxia, and tremor; metabolic/mitochondrial an., e.g., enzymatic defects; vegetative anomalies, e.g., breathing anom-
alies and increased sweating; behavioral anomalies, e.g., autism and aggression; ectodermal anomalies, e.g., skin, hair, and nail anom-
alies; and eye anomalies, structural and functional. Figure S2 shows the numbers of genes per clinical class and ID-accompanying
phenotype, a network view of the distribution of genes per clinical class, and a distribution of ID-accompanying phenotypes over
main clinical classes.molecular processes. Hence, this unsupervised analysis
predicts amultitude of previously undescribed ID-AG func-
tions (Figure 3 and Discussion).
In summary, phenotype-based cluster analyses systemat-
ically established gene-phenotype relationships in ID and
revealed compromised molecular processes and machin-
eries that underlie specific phenotype-defined subgroups
of ID disorders.
Phenotype Delineation of Groups of Process-Defined
ID Disorders
To define the typical phenotypic make-up of ID pathol-
ogies that are linked to specific biological processes, we
calculated enrichments of ID-accompanying phenotypes
among Gene Ontology-defined groups of ID-AGs in rela-
tion to their occurrence among all ID disorders (Figure 4).
ID disorders linked to mitochondria, for example, were
characterized by metabolic defects, myopathy, regression,
neurological features, lethality, non-structural MRI brain
defects, blood cell anomalies, and epilepsy, as commonly
appreciated.33 These features were between 1.6- and
6.9-fold more enriched in ID-AGs linked to specific pro-
cesses than in all ID-AGs (0.044 > padj > 2.45 3 10
29).
Among cilia-associated ID disorders, we found strong
enrichment of obesity and urogenital, renal, skeletal, eye,
and brain malformations, which are widely recognized
features of ciliopathies34 (4.4 < E < 13.1; 1.8 3 104 >
padj > 7.6 3 10
12), but also endocrine defects (E ¼ 5.2;
padj ¼ 2.3 3 104) and behavioral anomalies (E ¼
3.4; padj ¼ 1.6 3 103). ID-associated deficiencies in DNA
repair were defined by malignancies, ectodermal anoma-
lies, short stature, and microcephaly (4.1 < E < 8.8;The Amer3.23 104 > padj > 1.6 3 10
4). Chromatin-related ID dis-
orders can be identified by clefts, cardiac problems, other
malformations, limb anomalies, and short stature (2.6 <
E < 3.2; 1.1 3 102 > padj > 9.7 3 10
4). Clinical features
reached even higher enrichment among ID disorders
linked to specific signaling pathways, such as MAPK
signaling (top features: ectodermal anomalies and cardiac
malformations; E ¼ 3.0), Wnt signaling (top feature: other
malformations; E ¼ 7.0), hedgehog signaling (top feature:
limb anomalies; E ¼ 9.7), and BMP signaling (top feature:
vertebral and skull anomalies; E ¼ 103.3) (Figure 4).
In summary, systematic analyses of ID-AGs permitted
clinical delineation of groups of process-defined ID
disorders.
Clinical Classification of ID Disorders Disentangles
ID-Associated Genes into Biologically Meaningful
Modules
To reveal the extent to which human phenotypes can be
used for disentangling the large network of ID-AGs into
biologically meaningful, physically interacting modules,
we determined PIE scores for the clinical classes and for
the ID-accompanying phenotype categories and asked
whether these show a higher degree of connectivity than
the complete group of all ID-AGs (PIE ¼ 1.32, see above).
Most clinical classes (2–5, 7, and 8b) had significantly
higher PIE scores (1.7 % PIE % 10.8, padj < 0.05;
Figure 5A and Figure S3). Comparing the total number of
‘‘within-class’’ PPIs with the number of interactions in
randomly scrambled classes demonstrated that the dis-
ease-based classification successfully captures the molecu-
lar modularity of ID (E ¼ 1.68, p < 0.0001). The sameican Journal of Human Genetics 98, 149–164, January 7, 2016 155
Figure 3. Relationships among Genes, Phenotypes, and Molecular Function in ID
Hierarchical clustering of ID-AGs and ID-accompanying phenotypes. Phenotypic similarity of (groups of) ID-AGs is indicated by the
proximity of genes (x axis) and the proximity of ID-accompanying clinical features based on their co-occurrence in ID disorders (y
axis). Gene Ontology-based terms that were significantly enriched after multiple-testing corrections in two or more adjacent ID-accom-
panying phenotypes are displayed on the right-hand side. Colored rectangles highlight randomly chosen clusters. These are highly en-
riched with cilia (red), chromatin (yellow), synapses (turquoise), and mitochondria (blue). Genes within the clusters are shown in the
boxes below in the same color code. Those genes that are already associated with the respective Gene Ontology-based term are high-
lighted in bold. Abbreviations are as follow: an, anomalies; malf, malformation; non-struct, non-structural MRI anomalies; hedgehog,
hedgehog signaling; Wnt, Wnt signaling; MAPK, MAPK signaling; and response to GF, response to growth factor.was true for the ID-accompanying phenotype categories
(24 of 27 had PIE scores between 1.4 and 10.0 [Figure S3]
and were significantly enriched in ‘‘within accompanying
phenotype category’’ connectivity [E ¼ 1.96; p < 0.0001]).
We next asked whether discernible patterns that vali-
date biological coherence of clinically defined ID classes
also exist in other genome-wide data. In BrainSpan
gene-expression data, most clinical classes showed an
elevated level of co-expression in brain when they were
compared to the genomic background and all ID-AGs
(Figure 5B), and the level of co-expression of ID-AGs
within ID classes was significantly higher than for ID-
AGs that were randomly distributed over the ID classes
(E ¼ 1.07; p ¼ 0.012). Likewise, co-expression levels across
human tissues (GTEx) were elevated among most ID clas-
ses (Figure 5C) and among 24 of 27 ID-accompanying
phenotype categories (padj < 0.05 [except F, I, Ub, and E
¼ 1.13], p < 0.0001 for ID-accompanying phenotype clas-
ses versus randomly distributed ID-AGs).
In conclusion, annotation of ID-AGs to clinical classes
and ID-accompanying phenotypes demonstrated that
phenotype classification can deconvolute the large group156 The American Journal of Human Genetics 98, 149–164, January 7of ID-AGs into modules with elevated biological
coherence.
Added Value of Human Phenotype Classification for
Prediction of Disease-Associated Genes
We wondered whether publically available functional or
phenotype datasets would be enriched with specific ID
classes. Given that synapse biology has been proposed to
play a central role in ID,29,32 we first determined the dis-
tribution of 1,458 previously reported hPSD proteins.35
Although genes encoding hPSD proteins were highly rep-
resented among all ID-AGs (105 proteins, E ¼ 2.37, p <
0.0001), they were particularly enriched in ID classes 1,
3, and 6 while being strikingly underrepresented in classes
4 and 7 (Figure 5D). A similar distribution (highest enrich-
ment in non-syndromic classes 3 and 6 and striking under-
representation in class 7) was found when we matched
genes associated with co-morbid autism spectrum disorder
phenotypes (SFARI database)10 to ID classes (Figure 5E).
We then performed precision-recall analysis by using
a recently established phenotypic-linkage network21 to
determine the ability of ID-AGs to predict each other on, 2016
Figure 4. Phenotype Delineation of
Groups of Process-Defined ID Disorders
The typical phenotype combinations char-
acterizing ID disorders associated with a
specific molecular process or system were
defined according to the Gene Ontology-
based groups shown in Figure 1A. The vol-
cano plots show relative enrichments (x
axes in log10 scale) of ID-accompanying
phenotypes (A–X) among the indicated
molecular process or system in relation to
their occurrence among all 650 ID-AGs,
plotted against the corresponding p values
(y axes in log10 scale). Letters (A–X) refer
to ID-accompanying phenotypes as listed
in Figure 2B. ID-accompanying pheno-
types highlighted in red show significant
specificity (Benjamini Hochberg, padj <
0.05), thus identifying clinical features
that are characteristic of the respective mo-
lecular-process-defined ID disorder group.the basis of their increased functional similarity (compared
to that among random genes) (Figure 5F). The resulting
precision-recall curve was highly significant (p < 0.001),
reinforcing our findings that known ID-AGs show
considerable functional coherence to an extent that can
be exploited for prioritization and prediction of disease-
associated genes.
Strikingly, testing the added predictive value of individ-
ual ID clinical classes and categories (in comparison to that
of randomly selected ID-AGs) validated that particular clas-
ses of ID-AGs form sub-clusters of significantly increased
coherence and power. This was true for individual main
clinical classes (1, 4, and 8b), super-classes (syndromic ID
with structural malformations), and ID-accompanying
phenotypes (e.g., ID disorders with brain malformations,The American Journal of Human Gobesity, behavioral abnormalities,
and limb malformations; Figure 5G
and data not shown).
Together, our findings prove the
importance of phenotype consider-
ation in ID-AG prediction and demon-
strate the added value of our human-
phenotype-based classification system
to the predictive power.
Patterns in ID Are Revealed by
Custom-Made Drosophila
Phenotype Data
Lastly, because human phenotypic
information is often limited, we
also aimed to provide proof of
concept that relevant functional
and phenotypic information can be
generated in a customized manner.
We used Drosophila melanogaster, an
established model for ID geneticsand pathology,36 to generate two large-scale functional,
multiparametric datasets for ID-AGs annotated in an
earlier version of the SysID database (388 ID-AGs) by
RNAi-mediated knockdown of their fly orthologs. We
chose two assays covering different functional domains:
behavior and morphology. The RNAi approach is a
suitable global approximation to model the human
disease conditions because (partial) loss of gene function
is thought to be the causative mechanism for the vast
majority of these ID-AGs.37 We used a total of 570
RNAi lines, including two independent RNAi constructs
per gene whenever available (Table S2), and character-
ized ID knockdown models (1) in a behavioral assay
upon neuronal knockdown at two different time points
to distinguish early- and late-onset phenotypesenetics 98, 149–164, January 7, 2016 157
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Figure 5. Genomic, Proteomic, and Phenotype Datasets Define Predictive Patterns in ID
(A–E) 650 ID-AGs and clinical subsets were matched to public datasets and show patterns relating to clinical classes. (A) PPIs, (B) co-
expression in BrainSpan, (C) co-expression in GTEx, (D) hPSD, and (E) autism candidate genes. Enrichment scores are provided for
nine main classes (1–8b) and the total set of 650 ID-AGs (outer frame). (Benjamini-Hochberg, *padj < 0.05; **padj < 0.01; ***padj <
0.001.) Note that class 8b, belonging to the SWOSM super-class column, is depicted in the third column because of symmetry reasons
and because class 9 contains only a single gene.
(F) The predictive power of 650 ID-AGs to identify ID-AGs in leave-one-out analysis on the basis of proximity in the reference gene
network is illustrated by standard precision-recall analysis. Precision is defined as the number of correctly predicted ID-AGs as a propor-
tion of all genes predicted for a given recall. Recall is the proportion of all ID-AGs that are recovered. The significance of these predictions
was determined by comparison with precision-recall curves obtained with number-matched random genes. These are represented by
gray areas shaded to indicate the p values as shown in the legend and reveal the highly significant power of the 650 ID-AGs to predict
each other from the genome-wide background.
(G) Examples of precision-recall for individual ID clinical classes and ID-accompanying phenotype categories, notably from the 650
ID-AG background. Thus, deconvoluting ID-AGs according to phenotypes results in added predictive value (compared to that of random
IDA-Gs).
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(Figure 6A) and (2) in a morphological assay using
the wing as a model (Figures 6A and 6B and Tables
S2.1–S2.6).
We found that specific Drosophila phenotypes within
both screens were significantly more or less abundant
among ID-AGs than among non-ID-associated control
genes (Material and Methods). Upon neuronal ablation,
ID-AGs showed a consistent tendency for early-onset phe-
notypes (developmental lethality and all early behavioral
phenotypes), but not late-onset phenotypes (Figure 6C).
Progressive phenotypes (which become more frequent at
late testing time points than at early time points) could
be observed in more than 70% of controls but in only
40% of the ID-AG set, which was probably at least
partially attributable to increased developmental lethality
in the latter. In general, the congenital or early-onset
phenotype of ID as a (neuro)developmental disorder ap-
pears to be reflected in corresponding fly phenotypes
such as developmental lethality and early-onset behav-
ioral phenotypes. In the second screen, ID-AG ablation
in the wing revealed that phenotype rates associated
with ID-AGs were higher than those associated with the
control gene set. In particular, specific morphological phe-
notypes such as trichome and vein defects were highly
enriched (Figure 6D).
Resolving ID-characteristic Drosophila phenotypes such
as early behavioral phenotypes and wing morphological
phenotypes according to our human-ID-classification
system, we found that the identified ID phenotype pat-
terns did not arise from an overall enrichment of the
fly phenotype among ID models but rather derived
from specific clinical ID classes. For example, in the
neuronal screen, the phenotypes ‘‘early walker’’ and
‘‘early sitter’’ derived from a high enrichment of pheno-
types associated with ID-AG orthologs of classes 4 and
7 and 1, 4, and 7, respectively (Figure 6E). In the wing
screen, classes 4 and 7 were highly enriched with
Drosophila phenotypes ‘‘wing trichome density,’’ and
classes 3 and 7 were enriched with ‘‘wing veins missing,’’
suggesting that these can be considered phenologs38 of
these human phenotype classes (Figure 6F). Precision-
recall analysis21 of the fly phenotypes ‘‘early sitter’’ and
‘‘wing veins missing’’ (Figures 6D and 6E), analogous
to analysis of the human phenotypes (Figures 5F and
5G), revealed their predictive value (p < 0.01) (Figures
6E0 and 6F0). No striking patterns of enrichment were
observed for ID-atypical Drosophila late behavioral and
gross wing-growth phenotypes or for a number of other
phenotypes.
Together, the data generated inDrosophila provide exper-
imental support that ID-AGs exert important functions
during development, in agreement with the strong devel-
opmental origin of the human pathologies. Moreover, rela-
tions can be established between distinct phenotypes in
Drosophila and humans, providing evidence that cross-spe-
cies phenotyping can contribute to ID-AG prediction and
identification.The AmerDiscussion
To demonstrate that highly heterogeneous ID disorders can
be systematically broken down into biologically coherent
modules, we set up a curated inventory of currently known
ID-AGs and their associatedphenotypes, classified in anum-
ber of clinical categories and linked to various publically
available and previously undescribed functional data. We
provide an easily exploitable database (SysID database, see
Web Resources) representing a comprehensive resource
of ID-AGs, their properties, functional connectivity, and
gene-phenotype relations. These aspects are fundamental
to a better understanding of the molecular processes under-
lying cognitive (dys)function for furthering genetic diagnos-
tics and developing treatment strategies that aim to target
shared pathways and processes rather than single genes.
Apart from comprehensiveness, the main achievements
of our work in comparison to those of previous studies re-
porting ID-AG lists8,9,39–41 include (1) manual curation, (2)
a conservative annotation of ID-AGs only when indepen-
dent evidence from several individuals exists, and (3) a strat-
egy that integrates genes andphenotypes. In order to reduce
phenotypic complexity and to create amanageable amount
of clinical data, we applied a bipartite ID-classification sys-
tem based on (1) the manifestation, severity, penetrance,
and ‘syndromicity’ of ID and (2) recurrently reported
ID-accompanying phenotypes. Because inconsistent termi-
nology, incomplete phenotype annotation or functional
knowledge, diagnostic biases in published reports, and dis-
orders with only a few affected individuals limit reliability
in systematic phenotyping and are most likely more pro-
nounced in complex, high-resolution approaches (such as
that established by the Human Phenotype Ontology42,43),
we used a limited amount of 27 ID-accompanying pheno-
types covering main organ systems and features. Growing
clinical data and ongoing attempts to improve annotation
and curation of phenotyping and phenotype ontol-
ogies43–45 still need investment,44,46 but they hold potential
forphenomicsapproacheswitheventuallyhigher resolution.
This study systematically revealed quantitative overrep-
resentation of biological processes and molecular modules
in ID and used phenotypic information to distinguish
various biologically meaningful subgroups of ID-AGs.
The differential representation of genes encoding synaptic
(hPSD) proteins35 among clinical classes (Figure 5D), for
example, is striking. Differently selected groups of affected
individuals are thus likely to account for the reported dis-
crepancies in the contribution of genes with synaptic func-
tion to ID.30,47 Furthermore, genes associated with autism
spectrum disorders show a similar pattern, in agreement
with the notion that synapse biology is a major theme in
these disorders.32,48,49
Phenotypic and Molecular Coherence in ID and
Related Disorders
Our findings of phenotype-based functional modules
add to widely accumulated evidence that similar clinicalican Journal of Human Genetics 98, 149–164, January 7, 2016 159
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Figure 6. Custom-Made Functional Datasets in Drosophila Reveal Additional Patterns
(A) Schematic representation of the neuronal screen and assessed phenotypes. Viable pan-neuronal knockdown IDmodels were tested at
two different time points for their ability to escape from a platform.
(B) Phenotypes evaluated in the wing screen. Examples of genes (human orthologs) and associated phenotypes are shown.
(C) Phenotypes and their frequencies upon neuronal knockdown. Note that knockdown of ID-AGs (green) tended to cause early
phenotypes, whereas knockdown of non-ID-AGs (gray) caused significantly more late phenotypes.
(D) Phenotypes and their frequencies upon knockdown in the wing. ID-AGs are highly enrichedwith lethal, posterior-margin, andwing-
field phenotypes. Broad morphological phenotypes are evenly represented among ID-AGs and non-ID-AGs.
Bar graphs in (C) and (D) show genes in each phenotype group as a percentage of all genes in each dataset (264 ID-AGs in the neuronal
dataset, 261 ID-AGs in the wing dataset, and 31 non-ID-AGs in both assays). The p values were determined with Fisher’s exact test and
corrected for multiple testing (Benjamini-Hochberg, *padj < 0.05; **padj < 0.01; ***padj < 0.001). Note that each gene can be associated
with more than one phenotype.
(legend continued on next page)
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phenotypes are caused by genetic defects in common path-
ways and processes.50 However, phenotype-based system-
atic deconvolution of highly heterogeneous disorders has
not been accomplished previously.
Interestingly, a recent study reported significant con-
nectivity and anatomical specificity of ASD, but not
ID, on the basis of analysis of a single brain region, the
cerebral cortex, during a limited time window.8 Applying
our analysis to the published list of ASD-associated genes
(118 genes indicated as ASD, but not ID; 11 of these
genes are, however, convincingly implicated in syn-
dromic ID disorders) surprisingly revealed an overall
lower molecular connectivity of ASD-associated genes
(PIE ¼ 0.89) than of random genes (PIE ¼ 1) and our
ID-AG catalog (PIE ¼ 1.32). Likewise, co-expression in
the cerebral cortex across all stages was 2.4-fold higher
for all 650 ID-AGs than for the indicated ASD-associated
genes and even up to more than 4-fold higher in clinical
classes 1 and 4. This illustrates the extensive nature of
biological coherence in ID. Given that the observed co-
expression of ID-AGs can primarily be attributed to their
increased co-expression in the embryonic brain (E ¼ 1.05
[p < 0.0001] versus postnatal E ¼ 1.02 [p ¼ 0.06]), it will
be interesting to further map ID modules onto specific
embryonic stages and brain regions such as the cortex
and hippocampus.
Fundamental and Translational Potential of Human
and Drosophila Phenotypes
By establishing the relationships among genes, phe-
notypes, and molecular function, we have generated
knowledge and predictive value. First, clustering ID-AGs
according to their accompanying clinical features resulted
in a landscape of human phenotypes (Figure 3) and sug-
gested previously undescribed biological functions for
many of them, given that genes close to one another
are likely to share function. Five of 18 ID-AGs in our
highlighted, red cluster in Figure 3 have not yet been
annotated with cilia-related Gene Ontology terms. Strik-
ingly, a recent study demonstrated that one of these,
the GNAS (MIM: 139320)-encoded protein Gas, is highly
enriched at the primary cilium of granule neuron precur-
sors and regulates ciliary trafficking of hedgehog-pathway
components.51 HDAC8 might function in analogy to
HDAC6 and regulate cilia disassembly via acetylation of
tubulin.52 MAGEL2 was shown to co-immunoprecipitate
with BBS4,53 a ciliary protein present in the same cluster.
Second, this phenotype-based approach can also identify
indirect gene functions. The turquoise-labeled cluster,
enriched with genes encoding synaptic proteins, also con-
tains transcription factors DEAF1 and FOXP1, which have(E and F) Enrichment of early behavioral (early walker and early sitt
missing veins, F), resolved according to ID clinical classes, shows t
(Figure 6C) arises from enrichment of phenotypes in specific clinical
shows the significant predictive power of the custom-made phenot
phenotype. p value curves from number-matched, randomly sub-sam
The Ameralready been implicated in memory and synaptic func-
tion, respectively.54,55 Third, a specific combination of
phenotypes, biological processes, and gene function al-
lowed the recognition of typical phenotype combinations
characterizing groups of process-defined ID disorders,
such as chromatin-related ID disorders, ciliopathies, and
ID-associated deficiencies in DNA repair. Fourth, preci-
sion-recall analyses of phenotype-defined groups of ID-
AGs unambiguously demonstrated the added predictive
value of phenotypes and the phenotype-based classifica-
tion systems.
How can further informative phenotype data be gener-
ated in a fast, customized, and large-scale approach?
Cross-species phenotyping using efficient genetic models
has emerged as a promising approach with translational
potential.26,37,56,57 We generated two ID datasets in
Drosophila. Both highlight ID-AGs with important roles
in development, in perfect agreement with their associa-
tion with clinical classes 1, 4, and 7 (Figures 6E and 6F)
and thus with the super-class of syndromic ID with struc-
tural malformations. It is conceivable that other experi-
mental readouts in Drosophila would produce enrichments
among different clinical classes. Synapse or learning and
memory phenotypes, for example, might support non-
syndromic classes 3 and 6. Such patterns of a particular
fly phenotype similar to a specific human phenotype could
be exploited to support the causative nature of mutations
in ID-associated candidate genes by rapid, custom-made
assays in Drosophila.
In addition to providing insights into the biology and
modularity of ID, our study has immediate translational
benefit, including the broad applicability of our database,
which now contains 746 high-confidence ID-AGs and
associated data. The ID-AG catalog can serve as a basis for
either targeted sequencing of diagnostic gene panels or
evaluating data from exome or genome sequencing, as
already implemented in our diagnostic centers. Further-
more, we propose exploiting the patterns identified in
our study to not only contribute to the evaluation of novel
ID-AG candidates but also pursue the systematic char-
acterization of the underlying biological mechanisms.58
Because our experiments provide proof of principle that
functional data with translational value can be generated
in Drosophila on demand, application of efficient disease
models in diagnostic settings should be encouraged. In
conclusion, our gene catalog, human and cross-species
phenotype annotations, integrated analyses, and flexible
database provide a significant step toward overcoming cur-
rent limitations in ID research and diagnostics and the
basis for objective application of human phenotype and
functional annotations.er, E) and wing morphological phenotypes (trichome density and
hat the increased abundance of the phenotypes among ID-AGs
classes. (E0 and F0) Precision-recall analysis (see Figure 5 for details)
ypes to identify other ID-AG orthologs associated with the same
pled ID-AG sets are indicated.
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